Image of a scientist testing to show Life sciences COVID-19 testing and diagnostics statement

Life sciences’ COVID-19 testing and diagnostics statement

The life sciences industry has released a joint statement on COVID-19 testing and diagnostics as the Government confirms that testing capacity will increase. The statement...
Image of a target with an arrow in the middle to show Rapid COVID-19 diagnostic test to be deployed in hospitals

Rapid COVID-19 diagnostic test to be deployed in hospitals

A new rapid COVID-19 diagnostic test developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes,...
Image of a hospital corridor to show Interim analysis data for Siltuximab-Treated COVID-19 Patients from the SISCO Study

Interim analysis data for Siltuximab-Treated COVID-19 Patients study

An update on the Siltuximab clinical study brings interim analysis data for Siltuximab-Treated COVID-19. EUSA Pharma has announced the initial preliminary findings from the Papa...
Image of people sat at a meeting table to show More NICE rapid COVID-19 guidelines published

More NICE rapid COVID-19 guidelines published

NICE has published its second set of rapid COVID-19 guidelines which cover the provision of radiotherapy services and bone marrow transplant during the COVID-19...
Image of a three piles of coins and an increasing arrow to show COVID-19 pharmacy funding: Ministers agree £300m cash injection

COVID-19 pharmacy funding: Ministers agree £300m cash injection

Ministers have agreed a COVID-19 pharmacy funding package and will inject a total of £300 million of advance funding into community pharmacies over the...
Image of the article Medicines and Medical Devices Bill: Getting it right for all

Medicines and Medical Devices Bill: Getting it right for all

With the Medicines and Medical Devices Bill heading through Parliament, Claudia Rubin asks what is required to get this legislation right? The Government would like...
Image of a man and woman pushing together two halves of an arrow to show Sanofi and Translate Bio collaborate on novel mRNA vaccine for COVID-19

Sanofi and Translate Bio collaborate on novel mRNA vaccine for COVID-19

Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, will collaborate to develop a...
Image of people sitting around a table to show Chloroquine and Hydroxychloroquine not licensed for coronavirus treatment

Chloroquine and Hydroxychloroquine not licensed for coronavirus treatment

The MHRA has released guidance saying that Chloroquine and Hydroxychloroquine are not licensed for coronavirus treatment. Recent media reports have suggested that chloroquine can protect...
Image of compass on blue background with clouds and paper aeroplanes flying around to show AstraZeneca is donating face masks to healthcare workers around the world

AstraZeneca is donating face masks to healthcare workers around the world

AstraZeneca is donating nine million face masks to support healthcare workers around the world as they respond to the COVID-19 (novel coronavirus) global pandemic. AstraZeneca...
Image of scientists working around giant pots of medicines and blister packs to show Government protects high demand medicines for coronavirus patients

Government protects high demand medicines for coronavirus patients

The Government has protected high demand medicines for coronavirus patients, with more than 80 medicines used to treat COVID-19 patients in intensive care units...

Latest articles

Entries for the Pf Awards 2022 are officially open

Enter today! The Pf Awards 2022 are officially open

New Year | New Suite of Categories | New Candidates Would you like to be recognised as a top performer in the UK Pharmaceutical industry? Enter...
MHRA licenses Gedeon Richter’s Ryeqo for symptoms of uterine fibroids  

MHRA licenses Gedeon Richter’s Ryeqo for symptoms of uterine fibroids  

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a licence for Ryeqo▼ (relugolix combination therapy), for the treatment of moderate to severe...
NICE issues draft guidance on dependence-forming medicines

NICE issues draft guidance on dependence-forming medicines  

The National Institute for Health and Care Excellence (NICE) has issued a new draft guideline on shared decision-making which looks at safe prescribing and...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Ground-breaking AI test could transform breast cancer diagnosis and treatment

Ground-breaking AI test could transform breast cancer diagnosis and treatment

Panakeia’s PANProfiler Breast assay - the world’s first AI software that can predict biomarker status from digitally imaged routine pathology samples - has received...
NICE issues draft guidance on dependence-forming medicines

NICE issues draft guidance on dependence-forming medicines  

The National Institute for Health and Care Excellence (NICE) has issued a new draft guideline on shared decision-making which looks at safe prescribing and...
pharmafield logo - pharma news

Top 5 R&D hubs in the UK

Read this cover story in the June issue of Pf Magazine here.    Join us on a tour of inspirational research and development centres. ...
MHRA licenses Gedeon Richter’s Ryeqo for symptoms of uterine fibroids  

MHRA licenses Gedeon Richter’s Ryeqo for symptoms of uterine fibroids  

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a licence for Ryeqo▼ (relugolix combination therapy), for the treatment of moderate to severe...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription